AI-generated summary
The authors retrospectively compared repeated low-level red light therapy with low-dose atropine eye drops in 122 myopic children over two years. They report that myopia progression and axial length elongation were significantly less in the red light group at all follow-up points. Eight adverse events were reported in the red light group, without irreversible structural damage.
- Participants
- 122
- Who or what was studied
- Treatment-naive myopic children receiving repeated low-level red light or low-dose atropine therapy
- Limits stated in the abstract
- The study was retrospective, so treatment groups were not randomly assigned and the abstract does not state a control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Repeated low-level red light, Myopia, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.